Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Unknown 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 6Breast 3Gynecologic 2Dermatologic 2Other hematologic neoplasm 1Genitourinary 1Endocrine 1

Conditions

Melanoma 323Skin Neoplasms 164Carcinoma, Basal Cell 90Keratosis, Actinic 62Lymphoma, T-Cell, Cutaneous 60Breast Neoplasms 59Leukemia, Lymphocytic, Chronic, B-Cell 47Precursor Cell Lymphoblastic Leukemia-Lymphoma 46Mycosis Fungoides 46Lymphoma, Non-Hodgkin 46Sezary Syndrome 44Lymphoma, Follicular 44Lymphoma, Large B-Cell, Diffuse 43Lymphoma, B-Cell, Marginal Zone 43Lymphoma, Mantle-Cell 42Burkitt Lymphoma 42Hodgkin Disease 41Carcinoma, Squamous Cell 41Lymphoma, Large-Cell, Immunoblastic 40Neoplasms 39Multiple Myeloma 39Lymphoma 39Leukemia, Myeloid, Acute 35Leukemia, Myeloid, Accelerated Phase 32Myeloproliferative Disorders 31Leukemia, Myeloid, Chronic-Phase 31Congenital Abnormalities 30Leukemia, Hairy Cell 29Sarcoma 28Primary Myelofibrosis 28

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase NA × Patient Acceptance of Health Care × Dermatologic × Clear all
NCT04534868 2020-09-01

Patient Acceptance And Satisfaction of Teledermoscopy In General Practice In a Belgian Rural Area

Cliniques universitaires Saint-Luc- Université Catholique de Louvain

Phase NA Unknown
100 enrolled
Dermatologic

Patient Acceptance of Health Care, Skin Neoplasms, Patient Satisfaction

NCT02043184 2017-06-07

Improving Adherence to Oral Cancer Agents and Self Care of Symptoms Using an IVR

Michigan State University

Phase NA Completed
322 enrolled
BreastDermatologicGastrointestinalGenitourinaryOther hematologic neoplasm

Behavioral Symptoms, Breast Neoplasms, Depression, Leukemia, Melanoma, Neoplasms, Patient Acceptance of Health Care, Prostatic Neoplasms, Colorectal Neoplasms, Neurobehavioral Manifestations, Medication Adherence

Data powered by HemOnc (CC BY 4.0) Colophon âš¡